| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8831957 | International Journal of Surgery | 2018 | 22 Pages |
Abstract
Unlike clinical trial populations, Stage 2 colon cancer patients are often elderly, have high rates of dMMR tumours, are rarely offered chemotherapy, yet still have excellent outcomes. dMMR immunohistochemistry is being increasingly used to identify Stage 2 patients who do not require chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Matthew Grant, Andrew Haydon, Lewis Au, Simon Wilkins, Karen Oliva, Eva Segelov, Yoland Antill, Peter Carne, Pravin Ranchod, Adrian Polglase, Chip Farmer, Martin Chin, Roger Wale, Paul Simpson, Stephen Bell, Stewart Skinner, Paul McMurrick,